Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

JPH posts net income of $3.17 million at the end of 2016

2017-02-19

According to the financial statements of Jerusalem Pharmaceuticals Company JPH for the year 2016, Net profit after tax of the period reached 3,166,074 USD Compared with Net profit after tax 2,224,286 USD for 2015, a net increase in profit of 42.34%.Total assets of the company reached 53,224,319 USD compared with total assets of 51,192,232 USD at the end of year 2015, a net increase of 3.97%.Total liabilities of the company reached 12,816,937 USD compared with total liabilities of 14,983,341 USD at the end of year 2015, a net decrease of 14.45%. Net ownership equity of the company reached 40,407,382 USD (Including Non-Controlling Interests of 535,258 USD) compared with total owner equity of 36,208,891 USD (Including Non-Controlling Interests of 647,664 USD) at the end of year 2015, a net increase of 11.60%.Noting that paid-in capital increased from 17,060,000 USD in year 2015 to 18,000,000 USD of this year,a net increase of 5.51%


 

2021-10-21
Al-Quds Index in a narrow range amid an increase in 9M financial data disclosures anticipation

2021-10-17
PHARMACARE recommends distributing 10% cash dividends for the year 2020

2021-10-14
A transaction on the stocks of TRSUT raises the trading value in the PEX

2021-10-07
Al-Quds Index rebounds upwards in the first week of October

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013